Posted by Michael Wonder on 18 Jun 2017
Agenda for 21 June TC meeting
16 June 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Alemtuzumab (Lemtrada)
- Osimertinib mesylate (Tagrisso)
